|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Minireview |
Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0616
Embryonic stem (ES) cells are typically derived from the inner cell mass of the preimplantation blastocyst and can both self-renew and differentiate into all the cells and tissues of the embryo. Because they are pluripotent, ES cells have been used extensively to analyze gene function in development via gene targeting. The embryonic stem cell is also an unsurpassed starting material to begin to understand a critical, largely inaccessible period of development. If their differentiation could be controlled, they would also be an important source of cells for transplantation to replace cells lost through disease or injury or to replace missing hormones or genes. Traditionally, ES cells have been differentiated in suspension culture as embryoid bodies, named because of their similarity to the early postimplantation-staged embryo. Unlike the pristine organization of the early embryo, differentiation in embryoid bodies appears to be largely unpatterned, although multiple cell types form. It has recently been possible to separate the desired cell types from differentiating ES cells in embryoid bodies by using cell-type-restricted promoters driving expression of either antibiotic resistance genes or fluorophores such as EGFP. In combination with growth factor exposure, highly differentiated cell types have successfully been derived from ES cells. Recent technological advances such as RNA interference to knock down gene expression in ES cells are also producing enriched populations of cells and elucidating gene function in early development.
2 Correspondence. FAX: 734 763 1166; oshea{at}umich.edu
This article has been cited by other articles:
![]() |
M. P. Quinlan, S. E. Quatela, M. R. Philips, and J. Settleman Activated Kras, but Not Hras or Nras, May Initiate Tumors of Endodermal Origin via Stem Cell Expansion Mol. Cell. Biol., April 15, 2008; 28(8): 2659 - 2674. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Yocum, T. E. Gratsch, N. Leff, J. R. Strahler, C. L. Hunter, A. K. Walker, G. Michailidis, G. S. Omenn, K. S. O'Shea, and P. C. Andrews Coupled Global and Targeted Proteomics of Human Embryonic Stem Cells during Induced Differentiation Mol. Cell. Proteomics, April 1, 2008; 7(4): 750 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Torihashi, M. Kuwahara, T. Ogaeri, P. Zhu, M. Kurahashi, and T. Fujimoto Gut-Like Structures from Mouse Embryonic Stem Cells as an In Vitro Model for Gut Organogenesis Preserving Developmental Potential After Transplantation Stem Cells, December 1, 2006; 24(12): 2618 - 2626. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Matsuura, H. Kogo, T. Ogaeri, T. Miwa, M. Kuwahara, Y. Kanai, T. Nakagawa, A. Kuroiwa, T. Fujimoto, and S. Torihashi Crucial Transcription Factors in Endoderm and Embryonic Gut Development Are Expressed in Gut-Like Structures from Mouse ES Cells Stem Cells, March 1, 2006; 24(3): 624 - 630. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |